The Genetically Informed Neurobiology of Addiction (GINA) model

R Bogdan, AS Hatoum, EC Johnson… - Nature Reviews …, 2023 - nature.com
Addictions are heritable and unfold dynamically across the lifespan. One prominent
neurobiological theory proposes that substance-induced changes in neural circuitry promote …

Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

H Zhou, RL Kember, JD Deak, H Xu, S Toikumo… - Nature Medicine, 2023 - nature.com
Problematic alcohol use (PAU), a trait that combines alcohol use disorder and alcohol-
related problems assessed with a questionnaire, is a leading cause of death and morbidity …

Opioid Trail: Tracking Contributions to Opioid Use Disorder from Host Genetics to the Gut Microbiome

EP Duffy, RK Bachtell, MA Ehringer - Neuroscience & Biobehavioral …, 2023 - Elsevier
Opioid use disorder (OUD) is a worldwide public health crisis with few effective treatment
options. Traditional genetics and neuroscience approaches have provided knowledge about …

[HTML][HTML] Multi-ancestry study of the genetics of problematic alcohol use in> 1 million individuals

H Zhou, RL Kember, JD Deak, H Xu, S Toikumo… - medRxiv, 2023 - ncbi.nlm.nih.gov
Problematic alcohol use (PAU) is a leading cause of death and disability worldwide. To
improve our understanding of the genetics of PAU, we conducted a large cross-ancestry …

Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program

Y Cheng, C Dao, H Zhou, B Li, RL Kember… - Translational …, 2023 - nature.com
Smoking behaviors and alcohol use disorder (AUD), both moderately heritable traits,
commonly co-occur in the general population. Single-trait genome-wide association studies …

Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases.

JK Stratford, MU Carnes, C Willis, MS Minto… - medRxiv, 2024 - medrxiv.org
Genes influencing opioid use disorder (OUD) biology have been identified via genome-wide
association studies (GWAS), gene expression, and network analyses. These discoveries …

Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records

M Niarchou, S Sanchez-Roige, IA Reddy… - Translational …, 2024 - nature.com
Despite the benefits associated with longer buprenorphine treatment duration (ie,> 180
days)(BTD) for opioid use disorder (OUD), retention remains poor. Research on the impact …

Multi‐omics cannot replace sample size in genome‐wide association studies

DAA Baranger, AS Hatoum, R Polimanti… - Genes, Brain and …, 2023 - Wiley Online Library
The integration of multi‐omics information (eg, epigenetics and transcriptomics) can be
useful for interpreting findings from genome‐wide association studies (GWAS). It has been …

[HTML][HTML] Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability

B Holen, G Kutrolli, AA Shadrin, R Icick… - Drug and Alcohol …, 2023 - Elsevier
Background Opioid use disorder (OUD), a serious health burden worldwide, is associated
with lower cognitive function. Recent studies have demonstrated a negative genetic …

[HTML][HTML] A review of the genomics of neonatal abstinence syndrome

E Yen, N Gaddis, L Jantzie, JM Davis - Frontiers in Genetics, 2023 - frontiersin.org
Neonatal abstinence syndrome (NAS) is a constellation of signs of withdrawal occurring
after birth following in utero exposure to licit or illicit opioids. Despite significant research and …